Evanson Jeff - Insider Non-Derivative Transactions at Outlook Therapeutics, Inc. (OTLK) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 7, 2024, Evanson Jeff's relationship to Outlook Therapeutics, Inc. (OTLK) is Officer (CHIEF COMMERCIAL OFFICER), and currently has 808,459 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other OTLK insiders.
Data Source: SEC.
Evanson Jeff - Insider Non-Derivative Transactions of OTLK Common Stock
Evanson Jeff - Insider Non-Derivative Transactions at OTLK
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 8, 2024 | P -- (Common Stock) | 62484 | 0.42 | 808459 |
| Jan 21, 2023 | Sell -- (Common Stock) | 267000 | 1.11 | 745975 |
| Jan 20, 2023 | Sell -- (Common Stock) | 103255 | 1.22 | 1012975 |
| Jan 19, 2023 | Sell -- (Common Stock) | 33738 | 1.25 | 1116230 |
| Jan 18, 2023 | Sell -- (Common Stock) | 27162 | 1.31 | 1149968 |